Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

GLP-1 Receptor Agonists in Alzheimer’s Disease: Emerging Off-Label Neuroprotective Potential

GLP-1 receptor agonists show strong preclinical neuroprotective potential in Alzheimer’s disease through effects on insulin signaling, neuroinflammation, amyloid, tau, and brain metabolism. Human evidence remains mixed, with observational studies suggesting lower dementia risk but randomized trials yet to demonstrate a clinically meaningful disease-modifying benefit.

Alzheimer's Disease Treatments

Coconut Oil and Dementia

Alzheimer's Disease and Sleep Disruption

Is Alzheimer's Disease Transmissible?

Aromatherapy for Dementia

Differences Between Alzheimer's and Dementia

Alzheimer's Disease Diagnosis

Stem Cell Therapy for Alzheimer's

Mixed Dementia Prevention and Treatment

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Childhood Dementia Causes

See more featured articles »

AAM - Air pollution and Alzheimer's

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Dementia Treatment

AAM - Genetics of Alzheimer's

Amyloid Cascade Hypothesis

Gender and Alzheimer’s Risk

Alzheimer’s Disease and Gingko Biloba

Diet and Alzheimer's Disease

What Causes Dementia?

Antidepressants and Dementia: Is There a Link?

Dementia with Lewy Bodies

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Types of Alzheimer's Disease

Omega-3 and Alzheimer’s Disease

AAM - The Search for a Cure to Alzheimer's

Does Herpesvirus Cause Alzheimer's?

What are Amyloid Plaques?

Designing Dementia-Friendly Environments

Alzheimer's and Veganism

Biomarkers for Alzheimer's Disease

Dementia Symptoms

Childhood Dementia Signs and Symptoms

Alzheimer's Disease Symptoms

Alzheimer's Disease Epidemiology

Can Happiness Protect You from Dementia?

Alzheimer's Disease Questions

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

What is Mixed Dementia?

Pollution and Alzheimer's

Can Statins Protect Against Alzheimer’s Disease?

Dementia Diagnosis

Dancing Through Dementia: How Movement Aids Memory and Mood

Mythbusting: Misconceptions in Dementia

Alzheimer's Disease Causes

Alzheimer’s tangles and plaques: what’s the difference?

Inflammation and Alzheimer's Disease

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Dementia Prevention

Mixed Dementia Symptoms and Diagnosis

Does Depression and Anxiety Increase the Risk of Dementia?

Alzheimer’s Disease and Calcium Supplements

Migraines and Dementia

Antibody Research and Alzheimer’s Disease

What is Dementia?

Bright Light Therapy and Dementia

Integrated PET/MR for Alzheimer’s Disease

Alzheimer's Disease and the Microbiome

Alzheimer's Disease Prevention

Stress and Alzheimer's Disease

Transcutaneous Electrical Nerve Stimulation for Dementia

Latest Alzheimer's & Dementia News and Research

Astrocytes found to directly regulate memory consolidation during sleep

Research has shown that a good night's sleep has many benefits, including memory consolidation. How sleep enables the brain to strengthen memories is still not completely understood, but a new study published in Neuron reveals how astrocytes, brain cells known for supporting neurons and their functions, can directly regulate brain circuits involved in memory consolidation.

13 Aug 2026

Alzheimer's markers show crucial differences across diverse global populations

Established Alzheimer's markers are also detected in blood samples from Nigeria and Tanzania. But other proteins in the blood differ from those seen in a comparable group in Canada.

13 Aug 2026

Later-life estrogen therapy associated with lower risk of developing dementia

Use of hormone therapy later in life was associated with lower risk of developing dementia, according to a study published August 12, 2026, in Neurology, the medical journal of the American Academy of Neurology.

12 Aug 2026

High frequency brain waves help coordinate human working memory

Research from scientists at University of California San Diego School of Medicine and collaborators has shed new light on how the human brain coordinates working memory, the process in which the brain encodes information for immediate or short-term use.

12 Aug 2026

Modern blood thinners slow cognitive decline in Alzheimer's patients

People with both atrial fibrillation and Alzheimer's disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline.

12 Aug 2026

Survey: Most U.S. adults believe brain health habits should begin before age 40

A new national survey commissioned by The Ohio State University Wexner Medical Center finds most U.S. adults believe brain health habits should begin before age 40.

12 Aug 2026

Social disadvantage associated with increased mortality risk in women with early natural menopause

Early natural menopause is already associated with a higher long-term health burden. A new large-scale study demonstrates that cumulative social disadvantage-and in particular, unemployment-is strongly associated with an increased risk of all-cause mortality and cardiovascular disease, as well as a marked predisposition to dementia, in women with early natural menopause.

12 Aug 2026

Researchers tracked biological aging for decades and found a striking pattern in women

Accelerated biological age in midlife was associated with higher risks of cardiovascular disease and death in both men and women over nearly three decades of follow-up. Women with accelerated biological age also showed a higher risk of dementia, although adding biological age to standard risk factors provided only minimal additional predictive value.

12 Aug 2026

UH College of Pharmacy secures funding for three major health studies

University of Houston College of Pharmacy researchers have secured more than $1 million in new funding to support three separate studies targeting sepsis, Alzheimer's disease and related dementias, and depression in patients with sickle cell disease.

11 Aug 2026

Senescent brain immune cells secrete protein linked to cognitive decline

Brain-resident immune cells that have reached an old-age state called "senescence" secrete a protein that causes dysfunction in other brain cells, according to a study led by investigators at Weill Cornell Medicine.

11 Aug 2026

Shared cellular pathway drives neurodegeneration in rare childhood dementia and Alzheimer’s

Researchers at University of California San Diego and their colleagues have identified a key cellular pathway that drives brain degeneration in both a rare childhood disorder and the far more common Alzheimer's disease.

11 Aug 2026

Nocturnal micro-awakenings linked to genetic risk of Alzheimer's disease

What if certain signs of the disease were to manifest themselves subtly during sleep, long before the first memory problems appear? This is the line of inquiry being explored by a team of researchers at ULiège, with the support of the Stop Alzheimer's Foundation.

11 Aug 2026

New UH Health initiative targets Texas healthcare workforce shortage

Addressing Texas' growing healthcare workforce shortage and rising demand for care, the University of Houston has launched UH Health, an academic health enterprise designed to integrate education, research and community engagement across the University.

11 Aug 2026

New multi-protein blood test accurately detects late-stage Alzheimer's disease

Researchers have identified seven proteins in the blood that could enable better blood tests for Alzheimer's disease.

11 Aug 2026

Comprehensive brain cell map opens new avenues for Alzheimer's therapies

The brain's immune cells are increasingly recognized as key players in Alzheimer's disease, but exactly how they change as the disease develops has remained unclear.

11 Aug 2026

One cognitive ability stood out in a study of Western diets and Alzheimer’s risk genes

A Western dietary pattern was associated with faster attention decline among older adults carrying the APOE ε4 allele, while no significant cognitive associations emerged for a Prudent dietary pattern. However, the Western diet association lost statistical significance after excluding participants with possible baseline cognitive impairment, making the finding exploratory.

11 Aug 2026

Semaglutide slows blood protein signature linked to future dementia risk

A post hoc analysis of 2,970 older SELECT participants found that semaglutide slowed worsening of a 25-protein blood signature that predicts future dementia risk. Over 104 weeks, semaglutide produced larger effects on modeled 5-year than 20-year dementia risk, but whether these biomarker changes translate into less cognitive decline or dementia remains unknown.

10 Aug 2026

Faith-based screenings expand early dementia detection among African Americans

Alter Dementia, Dementia Care Aware (DCA) and SageNavigator facilitated more than 100 free, community-based cognitive screenings at the 2026 Alter Dementia Summit and Aging Well Expo in Atlanta, Georgia, for the 100 Minds Screening Project.

10 Aug 2026

Study links better midlife vascular health to nearly 13 more dementia-free years

A long-term study of 12,409 adults found that a greater burden of diabetes, hypertension, and current smoking in midlife was associated with substantially fewer years lived free of dementia. Adults with none of these risk factors had about 30.1 dementia-free years from age 55, compared with 17.5 years among those with all three, a difference of nearly 13 years.

10 Aug 2026

Simple biological age score flags higher cognitive decline risk in older adults

A study of 4,818 middle-aged and older Chinese adults found that higher light BioAge was associated with greater risks of cognitive impairment, episodic memory decline, and reduced mental intactness. The simple measure, based on age, creatinine, glucose, and CRP, added modest predictive information but requires further validation before clinical use.

10 Aug 2026